Aurora, CONCT05041491Now EnrollingIRB Ready

Pre-diabetes Clinical Trial in Aurora, CO

Access cutting-edge pre-diabetes treatment through this clinical trial at a research site in Aurora. Study-provided care at no cost to qualified participants.

Sponsored by University of Colorado, Denver

Quick Self-Assessment

See if you qualify for this Aurora location

Preparing your pre-screening questions…

Expert Care in Aurora

Access pre-diabetes specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related pre-diabetes treatment provided free

Apply for This Aurora Location

Check if you qualify for this pre-diabetes clinical trial in Aurora, CO

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Aurora

    Convenient for CO residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Aurora site if eligible
  4. 4Begin participation

About This Pre-diabetes Study in Aurora

Newly released guidelines recommend increased physical activity (PA) and reduced sedentary behaviors (SB) to improve glycemia and prevent the onset and progression of type 2 diabetes (T2D). Typically, 30-60 min bouts of PA are advocated per day. Although this approach increases PA, it does not decrease the length of the sedentary periods through the day. This is important because recent epidemiological data suggest that frequently interrupting sedentary time improves glucose control even in people who achieve the recommended levels of PA. Preliminary experimental data suggest that breaking up prolonged sedentary time by performing multiple short bouts (5 min) of PA throughout the day, may improve glycemia more than performing a single continuous bout of PA, and thereby potentially be a novel strategy to prevent T2D. The improvement in glycemia was observed even when the total amount of PA and total energy expenditure were matched, suggesting that how and when PA is performed over the day may matter more than how much PA is done. However, important gaps in knowledge remain including: (1) whether similar benefits on glucose control would be observed in adults with prediabetes, a clinically relevant population that is at high risk of developing T2D; (2) whether these effects are sustained or diluted over time, and (3) what are the mechanistic underpinnings. To address these gaps, the investigators propose to measure the acute and chronic effects of PA breaks on glucose control and the underlying mechanisms in individuals at risk of developing T2D. Sedentary men and women with prediabetes (n=66, 50% F) will be randomized to either an intervention designed to interrupt SB with 5-min bouts of brisk walking performed hourly for 9 hours/day, 5 days/week (BREAK) or a control condition consisting of 45-min of brisk walking performed as a single daily continuous bout, 5 days/week (ONE). The two 3-months interventions will be matched for total active time.

Sponsor: University of Colorado, Denver

Who Can Participate

Inclusion Criteria

Male and female
BMI of 18.5-40 kg/m2 and weight stable over the previous 6 months.
Age, 18-64 years old.
Fasting glucose of 100-125 mg/dL or fasting HbA1c of 5.7-6.4%, or 2h OGTT blood glucose of 140-199mg/dL based on the American Diabetes Association criteria for pre-diabetes. Fasting glucose, HbA1c and OGTT results ordered by the participant's provider within 3-months of the screening visit will be accepted, provided they fall within the measurement of error range established by the institution's lab standards. Additionally, consistent use of Metformin (1 year) to prevent prediabetes from developing diabetes will be accepted.
Less than 150 minutes of moderate-to-vigorous physical activity (MVPA) per week and more than 6 hours of sitting time per day, as self-reported by the volunteers using the International Physical Activity Questionnaire (IPAQ).
Less than 6500 of steps per day as measured by a pedometer over 5 days (at least 1 weekend day).
Passing medical and physical screening, and analysis of blood and urine screening samples.
Low-moderate caffeine use (\<3 cups/day).
Agree to refrain from any other structured exercise than the physical activity prescribed in each arm of the study.
Agree to eat control diets for 3 days before and during the Clinical and Translational Research Center (CTRC) visits;
Agree to refrain from taking any over-the-counter (including nonsteroidal anti-inflammatory drugs) or prescribed medication (apart from oral contraceptives) for 3 days prior to the inpatient CTRC visits;
Agree to wear a Fitbit® activity monitor and upload data on the website on a daily basis for the whole duration of the study.
Agree to follow the physical activity interventions and to be randomly assigned to one of the two arms of the study.
Agree to complete all the study procedures.

Exclusion Criteria

Pregnancy, breast-feeding or post-menopause for women.
Being considered unsafe to participate as determined by the study physician.
Ever having a history of systemic, psychiatric, neurological disease, or drug and alcohol abuse.
History of cardiovascular disease, diabetes, uncontrolled hypertension, untreated thyroid, renal, hepatic diseases, dyslipidemia or any other medical condition affecting weight or lipid metabolism.
Being positive for human immunodeficiency virus or hepatitis B or C.
Taking medications affecting weight, triglycerides, energy intake/energy expenditure, or sleep in the last 3 months.
Having abnormal blood chemistry and/or hematology as deemed significant by the study physician.
Being a smoker or having been a smoker in the 3 months prior to their screening visit.
Having donated over 400 mL of blood within 3 months (90 days) of screening for the study;
Working night shifts within 1 month of and throughout the study.
Not completing the trial days of BREAK and ONE during the screening period to assess the willingness and ability of the participant to perform each of the interventions.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Aurora?

Yes, this clinical trial (NCT05041491) has an active research site in Aurora, CO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Pre-diabetes Treatment Options in Aurora, CO

If you're searching for pre-diabetes treatment options in Aurora, CO, this clinical trial (NCT05041491) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Aurora research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pre-diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all pre-diabetes clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Aurora, CO

See all essential tremor clinical trials recruiting in Aurora — not just this study.

Browse Essential Tremor Trials in Aurora

Browse More Trials by Condition

Ready to Join in Aurora?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Aurora, CO